Koshy S S, Montrose M H, Sears C L
Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196, USA.
Infect Immun. 1996 Dec;64(12):5022-8. doi: 10.1128/iai.64.12.5022-5028.1996.
Enterotoxigenic Bacteroides fragilis (ETBF) cells produce a 20-kDa heat-labile metalloprotease toxin which is potentially important in the pathogenesis of diarrhea associated with this infection. Previous studies indicate that subconfluent HT29/C1 cells treated with the B. fragilis toxin (BFT) develop morphologic changes with dissolution of tight clusters and apparent swelling. Such alterations suggest toxin-stimulated reorganization of the cellular cytoskeleton. The purpose of the current study was to evaluate the effect of BFT on actin microfilaments (F-actin) and cell volume. As assessed by fluorescent phallicidin staining which detects F-actin, BFT treatment of HT29/C1 cells resulted in redistribution of F-actin with loss of stress fibers, a floccular staining pattern, and cellular membrane blebbing without quantitative changes in F-actin fluorescence intensity. The F-actin redistribution was time and concentration dependent. In contrast to the cell shrinkage observed in response to the F-actin-depolymerizing agents cytochalasin D and Clostridium difficile toxin A, BFT stimulated an increase in HT29/C1 cell volume of 10 to 25% (compared with control cells) over a 24-h time course. Only 10 to 30 ng of BFT per ml was necessary to stimulate a maximal increase in HT29/C1 cell volume. The effect of BFT on cell volume was persistent and dependent on the proteolytic activity of BFT. In agreement with cell viability assays indicating that BFT did not injure HT29/C1 cells, intoxicated cells exhibited regulatory volume decrease, suggesting that toxin-treated cells remain physiologically dynamic. We conclude that BFT acts on the intestinal epithelial cell cytoskeleton to alter F-actin structure and to stimulate an increase in HT29/C1 cell volume. Although these two activities of BFT appear to be linked, the precise sequence of cellular events following intoxication of HT29/C1 cells with BFT remains unclear. We hypothesize that these F-actin and cell volume changes may lead to an alteration in tight junction function in the polarized intestinal epithelium, contributing to the pathogenesis of diarrhea in ETBF infections.
产肠毒素脆弱拟杆菌(ETBF)细胞产生一种20 kDa的热不稳定金属蛋白酶毒素,其在与该感染相关的腹泻发病机制中可能具有重要作用。先前的研究表明,用脆弱拟杆菌毒素(BFT)处理的亚汇合HT29/C1细胞会发生形态学变化,紧密聚集物溶解且明显肿胀。这些改变提示毒素刺激了细胞细胞骨架的重组。本研究的目的是评估BFT对肌动蛋白微丝(F-肌动蛋白)和细胞体积的影响。通过检测F-肌动蛋白的荧光鬼笔环肽染色评估,BFT处理HT29/C1细胞导致F-肌动蛋白重新分布,应力纤维丧失,出现絮状染色模式,以及细胞膜起泡,而F-肌动蛋白荧光强度无定量变化。F-肌动蛋白的重新分布具有时间和浓度依赖性。与用F-肌动蛋白解聚剂细胞松弛素D和艰难梭菌毒素A处理后观察到的细胞收缩相反,BFT在24小时的时间过程中刺激HT29/C1细胞体积增加10%至25%(与对照细胞相比)。每毫升仅需10至30 ng的BFT即可刺激HT29/C1细胞体积最大增加。BFT对细胞体积的影响是持久的,并且依赖于BFT的蛋白水解活性。与表明BFT不会损伤HT29/C1细胞的细胞活力测定结果一致,中毒细胞表现出调节性体积减小,表明毒素处理的细胞在生理上仍具有动态性。我们得出结论,BFT作用于肠上皮细胞细胞骨架,改变F-肌动蛋白结构并刺激HT29/C1细胞体积增加。尽管BFT的这两种活性似乎相关,但HT29/C1细胞被BFT中毒后细胞事件的确切顺序仍不清楚。我们推测,这些F-肌动蛋白和细胞体积变化可能导致极化肠上皮中紧密连接功能的改变,从而促成ETBF感染中腹泻的发病机制。